Lamoth, Frederic http://orcid.org/0000-0002-1023-5597
Funding for this research was provided by:
University of Lausanne
Article History
Accepted: 29 March 2023
First Online: 8 May 2023
Declarations
:
: FL has received research funding from Gilead, MSD, Pfizer and Novartis, has participated to advisory boards of Gilead, MSD and Pfizer, and has received honoraria for conferences from Gilead and Mundipharma. All contracts were made with and fees paid to his institution (CHUV).
: This article does not contain any studies with human or animal subjects performed by any of the authors.